JP2024525512A5 - - Google Patents
Info
- Publication number
- JP2024525512A5 JP2024525512A5 JP2023581003A JP2023581003A JP2024525512A5 JP 2024525512 A5 JP2024525512 A5 JP 2024525512A5 JP 2023581003 A JP2023581003 A JP 2023581003A JP 2023581003 A JP2023581003 A JP 2023581003A JP 2024525512 A5 JP2024525512 A5 JP 2024525512A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- composition
- optionally
- condition
- chemically modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163202970P | 2021-07-01 | 2021-07-01 | |
| US63/202,970 | 2021-07-01 | ||
| PCT/US2022/035866 WO2023278799A1 (en) | 2021-07-01 | 2022-06-30 | Therapeutic nucleic acids and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525512A JP2024525512A (ja) | 2024-07-12 |
| JP2024525512A5 true JP2024525512A5 (cg-RX-API-DMAC7.html) | 2025-07-07 |
Family
ID=84690648
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023581003A Pending JP2024525512A (ja) | 2021-07-01 | 2022-06-30 | 治療用核酸及びその使用方法 |
| JP2023581043A Pending JP2024527340A (ja) | 2021-07-01 | 2022-06-30 | 核酸の経口送達用の製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023581043A Pending JP2024527340A (ja) | 2021-07-01 | 2022-06-30 | 核酸の経口送達用の製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20240285668A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4363434A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2024525512A (cg-RX-API-DMAC7.html) |
| KR (2) | KR20240028486A (cg-RX-API-DMAC7.html) |
| CN (2) | CN117897162A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2022303330A1 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3223495A1 (cg-RX-API-DMAC7.html) |
| WO (2) | WO2023278802A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3563859B1 (en) | 2012-08-13 | 2021-10-13 | Cedars-Sinai Medical Center | Cardiosphere-derived exosomes for tissue regeneration |
| CA2962444C (en) | 2014-10-03 | 2023-09-05 | Cedars-Sinai Medical Center | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy |
| EP3749344A4 (en) | 2018-02-05 | 2022-01-26 | Cedars-Sinai Medical Center | METHODS OF THERAPEUTIC USE OF EXOSOMES AND Y-RNAS |
| KR20250078993A (ko) * | 2022-09-30 | 2025-06-04 | 세다르스-신나이 메디칼 센터 | 치료용 핵산 및 그의 사용 방법 |
| KR20260074974A (ko) * | 2023-09-15 | 2026-05-27 | 세다르스-신나이 메디칼 센터 | 유전독성 스트레스를 약화시키고 심장 보호 효과를 발휘하는 trex-1 증강제 |
| WO2026035943A1 (en) | 2024-08-08 | 2026-02-12 | Cedars-Sinai Medical Center | Formulations for oral delivery of nucleic acids |
| WO2026035744A1 (en) | 2024-08-08 | 2026-02-12 | Cedars-Sinai Medical Center | Combination therapies for metabolic disease |
| KR20260065643A (ko) * | 2024-10-31 | 2026-05-11 | 성균관대학교산학협력단 | CU-rich RNA를 포함하는 근위축증 또는 근육 손상의 예방 또는 치료용 조성물 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7780873B2 (en) * | 2004-02-23 | 2010-08-24 | Texas A&M University System | Bioactive complexes compositions and methods of use thereof |
| DK2182969T3 (en) * | 2007-07-31 | 2017-02-27 | Univ Texas | Micro-RNA family that modulates fibrosis and its applications |
| CN102639700A (zh) * | 2009-09-30 | 2012-08-15 | 哈佛大学校长及研究员协会 | 通过调节自噬增强基因产物调节自噬的方法 |
| US10258698B2 (en) * | 2013-03-14 | 2019-04-16 | Modernatx, Inc. | Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions |
| US20160024575A1 (en) * | 2013-05-02 | 2016-01-28 | The Regents Of The University Of California | Circulating small noncoding rna markers |
| WO2015055857A1 (en) * | 2013-10-18 | 2015-04-23 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Rny-derived small rnas as biomarkers for atherosclerosis-related disorders |
| CA2962444C (en) * | 2014-10-03 | 2023-09-05 | Cedars-Sinai Medical Center | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy |
| HK1249108A1 (zh) * | 2015-01-20 | 2018-10-26 | 米拉根医疗股份有限公司 | Mir-92抑制剂及其用途 |
| WO2017136652A1 (en) * | 2016-02-04 | 2017-08-10 | Tarveda Therapeutics, Inc. | Stapled peptide conjugates and particles |
| WO2017193051A1 (en) * | 2016-05-06 | 2017-11-09 | The Trustees Of Princeton University | Methods of monitoring rnase l activity |
| CN111448317B (zh) * | 2017-12-22 | 2025-07-04 | 罗氏创新中心哥本哈根有限公司 | 包含二硫代磷酸酯核苷间键的缺口聚物寡核苷酸 |
| EP3749344A4 (en) * | 2018-02-05 | 2022-01-26 | Cedars-Sinai Medical Center | METHODS OF THERAPEUTIC USE OF EXOSOMES AND Y-RNAS |
| US12258594B2 (en) * | 2018-12-05 | 2025-03-25 | The Broad Institute, Inc. | Cas proteins with reduced immunogenicity and methods of screening thereof |
| WO2020131986A1 (en) * | 2018-12-21 | 2020-06-25 | Pioneer Hi-Bred International, Inc. | Multiplex genome targeting |
| WO2026035744A1 (en) * | 2024-08-08 | 2026-02-12 | Cedars-Sinai Medical Center | Combination therapies for metabolic disease |
| WO2026035943A1 (en) * | 2024-08-08 | 2026-02-12 | Cedars-Sinai Medical Center | Formulations for oral delivery of nucleic acids |
-
2022
- 2022-06-30 KR KR1020247003755A patent/KR20240028486A/ko active Pending
- 2022-06-30 JP JP2023581003A patent/JP2024525512A/ja active Pending
- 2022-06-30 AU AU2022303330A patent/AU2022303330A1/en active Pending
- 2022-06-30 KR KR1020247003744A patent/KR20240027814A/ko active Pending
- 2022-06-30 WO PCT/US2022/035870 patent/WO2023278802A1/en not_active Ceased
- 2022-06-30 JP JP2023581043A patent/JP2024527340A/ja active Pending
- 2022-06-30 US US18/572,067 patent/US20240285668A1/en active Pending
- 2022-06-30 AU AU2022303384A patent/AU2022303384A1/en active Pending
- 2022-06-30 CN CN202280059718.0A patent/CN117897162A/zh active Pending
- 2022-06-30 WO PCT/US2022/035866 patent/WO2023278799A1/en not_active Ceased
- 2022-06-30 US US18/571,924 patent/US20250025487A1/en active Pending
- 2022-06-30 CN CN202280059708.7A patent/CN117916249A/zh active Pending
- 2022-06-30 EP EP22834283.8A patent/EP4363434A4/en active Pending
- 2022-06-30 CA CA3223495A patent/CA3223495A1/en active Pending
- 2022-06-30 EP EP22834280.4A patent/EP4362954A4/en active Pending
- 2022-06-30 CA CA3223686A patent/CA3223686A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12377056B2 (en) | Cladribine regimen for treating multiple sclerosis | |
| JP2025501731A5 (cg-RX-API-DMAC7.html) | ||
| US20240285668A1 (en) | Formulations for oral delivery of nucleic acids | |
| JP6430554B2 (ja) | 多発性硬化症を治療するためのクラドリビン投薬計画 | |
| JP2024527340A5 (cg-RX-API-DMAC7.html) | ||
| JP2025500824A5 (cg-RX-API-DMAC7.html) | ||
| JP2025534332A (ja) | 治療用核酸及びその使用方法 | |
| JP2000509715A (ja) | 炎症を処置するための方法 | |
| EP0329609B1 (en) | Antiviral combination | |
| US20160324986A1 (en) | Compositions and methods for providing active telomerase to cells in vivo | |
| SK281806B6 (sk) | Použitie il-10 na prípravu liečiva na prevenciu diabetes mellitus | |
| US20240269255A1 (en) | Hpv infectious disease vaccine | |
| US7335647B2 (en) | Drugs for liver diseases | |
| JP4011618B2 (ja) | 複合治療におけるtnfレセプター及びステロイドホルモン | |
| KR20240009952A (ko) | 인플루엔자 바이러스 핵산 지질 입자 백신 | |
| Chiang et al. | Pharmacokinetics and antiviral activity of recombinant human interferon-βser17 in African green monkeys | |
| Siddiqui et al. | Intramuscular Interferon-β-1a: In Patients at High Risk of Developing Clinically Definite Multiple Sclerosis | |
| WO2025188663A1 (en) | Methods for the treatment of diabetes-associated autonomic neuropathy | |
| EP4611791A1 (en) | Recombinant il-12 albumin binding domain fusion proteins for use in methods for the treatment of cancer | |
| JP2023170339A (ja) | 拡張型心筋症を処置または予防するための医薬組成物 | |
| JP2003137812A (ja) | 心不全の予防及び/又は治療剤 | |
| CN101500598A (zh) | 治疗多发性硬化症的克拉屈滨方案 | |
| WO2006091661A1 (en) | Compositions for and methods of modulating platelet levels | |
| HK1127753B (en) | Combination of interferon-beta and a cladribine regimen for treating multiple sclerosis |